Gala Therapeutics Receives FDA Approval to Commence Pivotal Trial to Evaluate the RheOx ...

Retrieved on: 2021-02-22 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Gala Therapeutics Receives FDA Approval to Commence Pivotal Trial to Evaluate the RheOx .... View article details on hiswai:

Excerpt

(Gala), a developer of medical devices to treat pulmonary disease, announces U.S. Food and Drug Administration (FDA) conditional Investigational ...

Article found on: www.prnewswire.com